Wolverine Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500
Closed -$2K 1767
2025
Q4
$2K Hold
500
﹤0.01% 1540
2025
Q3
$4.23K Hold
500
﹤0.01% 1440
2025
Q2
$5.63K Hold
500
﹤0.01% 1430
2025
Q1
$4.74K Hold
500
﹤0.01% 1377
2024
Q4
$5.63K Buy
+500
New +$8.79K ﹤0.01% 1408
2022
Q1
Sell
-1,400
Closed -$38K 2220
2021
Q4
$38K Hold
1,400
﹤0.01% 1582
2021
Q3
$43K Hold
1,400
﹤0.01% 1458
2021
Q2
$29K Hold
1,400
﹤0.01% 1815
2021
Q1
$28K Sell
1,400
-123,900
-99% -$2.36M ﹤0.01% 1725
2020
Q4
$2.01M Buy
125,300
+1,400
+1% +$18.5K 0.01% 458
2020
Q3
$1.54M Hold
123,900
0.01% 460
2020
Q2
$882K Sell
123,900
-9,400
-7% -$63K 0.01% 575
2020
Q1
$723K Sell
133,300
-171,300
-56% -$1.53M 0.01% 589
2019
Q4
$2.76M Buy
+304,600
New +$2.47M 0.03% 371
2019
Q3
Sell
-100,000
Closed -$795K 1444
2019
Q2
$795K Hold
100,000
0.01% 726
2019
Q1
$1.26M Buy
+100,000
New +$1.58M 0.02% 583
2017
Q2
Sell
-1,100
Closed -$24K 1316
2017
Q1
$24K Hold
1,100
﹤0.01% 1080
2016
Q4
$16K Buy
+1,100
New +$21.7K ﹤0.01% 1096

Other funds holding EVH

Wolverine Asset Management's EVH Position: Q1 2026 in Review

Wolverine Asset Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 487 shares — an estimated $1.95K sold.

Wolverine Asset Management first reported a position in EVH in Q2 2017 and held it in 8 quarters. The position peaked at $2.22M in Q2 2019. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Wolverine Asset Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 487 Evolent Health shares in Q1 2026, an estimated $1.95K.
  • Wolverine Asset Management first reported a position in Evolent Health in Q2 2017 and held it in 8 quarters.
  • Wolverine Asset Management's Evolent Health position peaked at $2.22M in Q2 2019.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.